4 ms·

Or to approach the same issue from the other direction: Does public funding for research of this type self-sabotage, if it enables pharmaceutical companies to s

by abeppu 6y ago

Or to approach the same issue from the other direction: Does public funding for research of this type self-sabotage, if it enables pharmaceutical companies to set pricing at a level which meaningfully limits the use of the results of that research?

fastball 6y ago
How exactly are is big pharma limiting the result of that research? Anyone can use the research.
- Robotbeat 6y ago
  If the patents relating to likely avenues of that research are tied up, it makes it much harder.
  - fastball 6y ago
    How can you patent if there is open prior art?
    - Robotbeat 6y ago
      You patent the necessary later steps, not the prior art itself. Companies have a pretty good method.
      - fastball 6y ago
        What is "prior art" when we're talking about profiting off of research if not the necessary steps to do something?
- refurb 6y ago
  Anyone can’t use the research. Bayh-Dohl Act basically passes ownership of any IP to the person who received the grant. https://en.m.wikipedia.org/wiki/Bayh–Dole_Act https://en.m.wikipedia.org/wiki/Bayh–Dole_Act